Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT03037476 Completed - Substance Abuse Clinical Trials

Personalized Health Assessment Related to Medications (Project PHARM)

Start date: March 30, 2017
Phase: N/A
Study type: Interventional

This research will adapt an evidence based intervention for alcohol and other drugs and evaluate its efficacy on Prescription Stimulant Medication (PSM) misuse in a web-based format for use with college students who have misused PSMs.

NCT ID: NCT03028532 Completed - Sports Drug Abuse Clinical Trials

Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting

Start date: March 13, 2017
Phase: Phase 1
Study type: Interventional

Clomiphene (Clomid) is a drug FDA approved to treat female infertility, however, it is often used by men in an off-label setting to both treat male infertility and in a multitude of sports disciplines to increase performance. Study Objectives: - Determine detection windows for clomiphene and its metabolites in urine following a medium-term administration - Understand the effect of clomiphene administration on luteinizing hormone (LH), follicle-stimulating hormone (FSH), and serum testosterone (T) concentrations in a longitudinal manner - Identify changes in current steroidal module of Athlete Biological Passport

NCT ID: NCT03023930 Completed - Opioid Use Disorder Clinical Trials

Opioid Use Disorder in the Emergency Department: CTN 0069

Start date: April 3, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient engagement in formal addiction treatment at 30 days.

NCT ID: NCT03016598 Completed - Clinical trials for Stimulant Use & Co-occuring Opioid Use Disorders

Stimulant Oxytocin Study

SOS
Start date: January 26, 2018
Phase: Phase 2
Study type: Interventional

This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with stimulant use disorders and enrolled in opioid replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).

NCT ID: NCT03015805 Completed - Substance Abuse Clinical Trials

Teen Success Project

JPO-CM
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of Juvenile Probation Officers (JPOs) delivering Contingency Management (CM) to teens on their caseload who have problems with drug use. CM has already been shown to be effective at helping teens with drug problems but CM has never been delivered by JPOs. This study will test how well it works to have JPOs deliver CM during their regular meetings with teens.

NCT ID: NCT03013478 Completed - Substance Abuse Clinical Trials

Computer Based Training in CBT in Primary Care

Start date: November 2016
Phase: N/A
Study type: Interventional

To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT to treatment as usual in a community based primary care program in a population of 60 individuals who meet current DSM criteria for substance use disorder other than nicotine.

NCT ID: NCT03012087 Completed - Clinical trials for Prescription Drug Abuse

Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers

Start date: September 2016
Phase: N/A
Study type: Interventional

The aim of this study is to pilot test a web-based, patient-centered educational program that encourages the patient to have an informed discussion about pain medication options with their emergency department (ED) provider.

NCT ID: NCT03000699 Completed - Clinical trials for Substance Dependence

Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether computer bias modification for interpretation bias (CBM-I) is effective in the reduction of suicidal ideation in substance use disorders.

NCT ID: NCT02986841 Completed - Substance Abuse Clinical Trials

A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2

Start date: May 10, 2016
Phase:
Study type: Observational

This is a 4-phase study to implement the NIDA (Common Data Elements) Common Data Elements (CDEs) in primary care settings. The study will be conducted at three adult primary care clinics, in two large health systems. Each phase will include deliverables essential to move to the next phase, and an independent Advisory Committee will review progress and make recommendations at each transition about how best to progress to each subsequent phase. Based on progress during earlier phases, the Advisory Committee may recommend expansion to additional clinics or health systems during the second part of Phase 4. Phase 2 prepares for implementation of the screening and CDS tools as part of routine clinical practice. A key component of this phase is tailoring the screening and CDS tools through an iterative process of usability testing and adaptation of their design. In the KTA framework, this phase corresponds to the 'select, tailor, and implement interventions' step. Simultaneously, investigators will plan for implementation in one clinic of the MSHS system by identifying clinical champions, educating clinic leadership and staff, and conducting a workflow analysis to identify barriers and facilitators of implementation.

NCT ID: NCT02981849 Completed - Substance Abuse Clinical Trials

Validating Adolescent SBIRT Measures

Start date: January 2016
Phase:
Study type: Observational

The purpose of this study is to address the needs for efficient and informative measurement for evaluating adolescent Screening, Brief Intervention, and Referral to Treatment (SBIRT) strategies. The investigators will undertake a longitudinal cohort study to build and validate a substance specific measurement battery that includes patient-centered and intermediary outcomes which can be integrated into a range of healthcare and research settings. The results of this project will enable evaluation of SBIRT trials and clinical efforts by validating a parsimonious set of measurement tools that can be incorporated into electronic health records. The primary goal of the proposed project is to develop a set of brief, valid tools that will allow both researchers and clinicians to collect information that enables evaluating and refining brief interventions. The main objective is to define and disseminate a set of brief and easy to administer measures that accurately detect 1) substance use frequency, 2) substance-specific patient centered outcomes and 3) intermediate measures of impact of adolescent SBIRT. The specific aim addressed in this project is to develop and administer an assessment battery that includes novel questions assessing substance use to be validated against criterion standard measures both cross-sectionally and longitudinally.